極度のリスクの患者におけるミトラアヌロトリプシーの実行可能性,有効性,および安全性
Gennaro Giustino1, Chantal Y Asselin1, Mostafa Naguib1
1Gagnon Cardiovascular Institute, Atlantic Health System, Morristown, New Jersey, United States.
Structural heart : the journal of the Heart Team
|September 2, 2025
まとめ
MATRIX技術による血管内リトトリプシー (IVL) は,高リスクの患者に重度の筋筋狭窄症を治療するための安全で効果的な代替手段です. この新しいアプローチは 伝統的な風船飛行なしに mitra グラデーションを大幅に減らすことができます
科学分野:
- 心臓病科
- 介入心臓科
- 構造 的 心臓 病
背景:
- 重度の縮性ミトラス狭窄症は治療上の大きな課題を提示する.
- 血管内リトトリプシー (IVL) は,従来の治療に不適した患者の皮膚経気球ミトラルバルブ整形手術において有望である.
- より大きな風船を使用した IVL テクニックは,パンフレットの折りたたみを改善し,傾斜を減らすことを目的としています.
研究 の 目的:
- 重度の状筋狭窄症に対する IVL 改定技術 (MATRIX) の実行可能性と安全性を評価する.
- IVLの高リスク患者のトランスバルブラー・グラデントの減少における有効性を評価する.
- IVLで不適合のバルブ整形手術の必要性を回避できるかどうかを判断する.
主な方法:
- 3つのセンターで7人の高リスク患者にミトラルアヌロトリプシー (MATRIX) を実施した.
- IVLバルーンは,トランスキャテータによるミトラル弁置換が禁忌の患者で,トランスセプト・シート経由で投与された.
- IVL治療は,平均ミトラグラデント (mMG) の満足のいく減少が達成されるまで繰り返した.
主要な成果:
- 患者の平均年齢は78歳,女性14.3%で,すべてNYHAクラスIII-IVでした.
- 前MATRIX mMGは9. 0 mmHgであり,最終的なmMGは3. 0 mmHgに減少した (絶対差は6. 3 mmHg,p < 0. 01).
- IVL後,従来のバルブ整形手術の風船は使用されなかった.すべての患者は手術を許容し,重大な合併症やミトラル吐の悪化はなかった.
結論:
- カルシフ・ミトラス狭窄症のIVLを用いたMATRIX技術は,マルチセンター環境では実行可能で安全です.
- このアプローチは,高リスクの患者で平均ミトラグラデントを効果的に減少させます.
- IVLは標準的な治療法に適合しない重度のミトラス狭窄症の患者にとって有望な代替手段です.
関連する概念動画
Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
Mitral Regurgitation III: Medical Management
28
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
28
Mitral Valve Prolapse II: Assessment and Management
39
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39
Mitral Stenosis II: Clinical features and Diagnostic Tests
37
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
37
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
50
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
50
Mitral Stenosis I: Introduction
34
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
34


